Costello Syndrome
8
6
6
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Clinical Genetics Branch Eligibility Screening Survey
Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
RASopathy Biorepository
Prevalence and Characterization of Pain in RASopathies
Solid Tumors in RASopathies
Effect of RAS/MAPK Pathway Hyperactivation on Growth' and Bone' Profile of the RASopathies
Pathophysiology Analysis of "Costello Syndrome" on Cellular Models